Who is sponsoring NCT04905641?

NCT04905641 is sponsored by Mahidol University.

What drugs are being tested in NCT04905641?

Interventions in NCT04905641: Bilateral intermediate cervical plexus block.

What condition does NCT04905641 study?

NCT04905641 studies Parathyroid Adenoma, Thyroid Nodule.

Is NCT04905641 still recruiting?

NCT04905641 is currently completed. Last updated 1 June 2021.

Last reviewed 2021-06-01 · How we verify

NCT04905641

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Feasibility of Bilateral Intermediate Cervical Plexus Block for Thyroidectomy/Parathyroidectomy

Completed Last updated 1 June 2021

What this trial tests

trial testing Bilateral intermediate cervical plexus block in Parathyroid Adenoma in 19 participants. Completed in 31 July 2017.

Timeline

10 March 2016

Primary endpoint
25 May 2017

31 July 2017

Quick facts

Lead sponsor	Mahidol University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	19
Start date	10 March 2016
Primary completion	25 May 2017
Estimated completion	31 July 2017
Sites	1 location across Thailand

Drugs / interventions tested

Bilateral intermediate cervical plexus block

Conditions studied

Parathyroid Adenoma — all drugs for Parathyroid Adenoma →
Thyroid Nodule — all drugs for Thyroid Nodule →

Sponsor

Mahidol University

Who can join

Eligibility, any sex, with Parathyroid Adenoma or Thyroid Nodule. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was evaluated the feasibility of bilateral intermediate cervical plexus blockade to be anesthesia for simple thyroid/parathyroid surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Parathyroid Adenoma

Currently open trials in the same condition.

NCT06913296 — PTeye in Parathyroid Adenoma · recruiting
NCT05891769 — 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT · Phase 2, PHASE3 · recruiting

Other Mahidol University trials

Trials by the same sponsor.

NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04905641 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mahidol University
Last refreshed: 1 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04905641.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing